Differential association of docosahexaenoic and eicosapentaenoic acids with carotid intima-media thickness

Stroke

Volumn 42, Issue 9, 2011, Pages 2538-2543

  Sekikawa, Akira ^a,b   Kadowaki, Takashi ^a,b   El Saed, Aiman ^a   Okamura, Tomonori ^b,c   Sutton Tyrrell, Kim ^a   Nakamura, Yasuyuki ^d   Evans, Rhobert W ^a   Mitsunami, Ken Ichi ^b   Edmundowicz, Daniel ^a   Nishio, Yoshihiko ^b   Nakata, Katsumi ^a   Kadota, Aya ^b   Otake, Teruo ^a   Miura, Katsuyuki ^b   Choo, Jina ^a   Abbott, Robert D ^b,e   Kuller, Lewis H ^a   Curb, J David ^b,f   Ueshima, Hirotsugu ^b  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^c KEIO UNIVERSITY   (Japan)

^d KYOTO WOMEN'S UNIVERSITY   (Japan)

^e UNIVERSITY OF VIRGINIA   (United States)

^f UNIVERSITY OF HAWAII   (United States)

Author keywords

carotid arteries; docosahexaenoic acid; eicosapentaenoic acid; imaging; population study

Indexed keywords

CHOLESTEROL; DOCOSAHEXAENOIC ACID; FATTY ACID; ICOSAPENTAENOIC ACID;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; CARDIOVASCULAR RISK; CAROTID ARTERY; FATTY ACID BLOOD LEVEL; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; UNITED STATES;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CAROTID ARTERIES; CAROTID ARTERY DISEASES; COHORT STUDIES; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; EUROPEAN CONTINENTAL ANCESTRY GROUP; HUMANS; JAPAN; MALE; MIDDLE AGED; PENNSYLVANIA; RISK FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EID: 80052413371     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.613042     Document Type: Article

References (22)

1. Wang C, Harris WS, Chung M, Lichtenstein AH, Balk EM, Kupelnick B, et al. N-3 fatty acids from fish or fish-oil supplements, but not {alpha}-linolenic acid, benefit cardiovascular disease outcomes in primary-and secondary-prevention studies: A systematic review. Am J Clin Nutr. 2006;84:5-17.
2. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: Evaluating the risks and the benefits. JAMA. 2006;296:1885-1899.
3. Balk E, Chung M, Lichtenstein A, Chew P, Kupelnick B, Lawrence A, et al. Effects of omega-3 fatty acids on cardiovascular risk factors and intermediate markers of cardiovascular disease. Evidence report/technology assessment no. 93. Rockville, MD: Agency for Healthcare Research and Quality; 2004.
4. Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y, et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among japanese: The japan public health center-based (jphc) study cohort i. Circulation. 2006;113:195-202.
5. Yokoyama M, Origasa H, Matsuzaki M, Matsuzawa Y, Saito Y, Ishikawa Y, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (jelis): A randomised open-label, blinded endpoint analysis. Lancet. 2007;369:1090-1098.
6. Stamler J, Elliott P, Chan Q, for the INTERMAP Research Group. Intermap appendix tables. J Hum Hypertens. 2003;17:665-775.
7. Lorenz MW, von Kegler S, Steinmetz H, Markus HS, Sitzer M. Carotid intima-media thickening indicates a higher vascular risk across a wide age range: Prospective data from the carotid atherosclerosis progression study (caps). Stroke. 2006;37:87-92.
8. Mori TA, Watts GF, Burke V, Hilme E, Puddey IB, Beilin LJ. Differential effects of eicosapentaenoic acid and docosahexaenoic acid on vascular reactivity of the forearm microcirculation in hyperlipidemic, overweight men. Circulation. 2000;102:1264-1269.
9. Woodman RJ, Mori TA, Burke V, Puddey IB, Barden A, Watts GF, et al. Effects of purified eicosapentaenoic acid and docosahexaenoic acid on platelet, fibrinolytic and vascular function in hypertensive type 2 diabetic patients. Atherosclerosis. 2003;166:85-93.
10. Weldon SM, Mullen AC, Loscher CE, Hurley LA, Roche HM. Docosahexaenoic acid induces an anti-inflammatory profile in lipopolysaccharide-stimulated human thp-1 macrophages more effectively than eicosapentaenoic acid. The Journal of Nutritional Biochemistry. 2007;18: 250-258.
11. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am J Clin Nutr. 2006;83: S1467-S1476.
12. Sala-Vila A, Cofan M, Perez-Heras A, Nunez I, Gilabert R, Junyent M, et al. Fatty acids in serum phospholipids and carotid intima-media thickness in spanish subjects with primary dyslipidemia. Am J Clin Nutr. 2010;92:186-193.
13. Lindqvist HM, Sandberg A-S, Fagerberg B, Hulthe J. Plasma phospholipid epa and dha in relation to atherosclerosis in 61-year-old men. Atherosclerosis. 2009;205:574-578.
14. Sekikawa A, Curb JD, Ueshima H, El-Saed A, Kadowaki T, Abbott RD, et al. Marine-derived n-3 fatty acids and atherosclerosis in japanese, japanese-american, and white men: A cross-sectional study. J Am Coll Cardiol. 2008;52:417-424.
15. Erkkila AT, Matthan NR, Herrington DM, Lichtenstein AH. Higher plasma docosahexaenoic acid is associated with reduced progression of coronary atherosclerosis in women with cad. J Lipid Res. 2006;47: 2814-2819.
16. Mori TA, Woodman RJ. The independent effects of eicosapentaenoic acid and docosahexaenoic acid on cardiovascular risk factors in humans. Curr Opin Clin Nutr Metab Care. 2006;9:95-104.
17. De Caterina R, Liao JK, Libby P. Fatty acid modulation of endothelial activation. Am J Clin Nutr. 2000;71:213S-223S.
18. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005;352:1685-1695.
19. Mori TA, Woodman RJ, Burke V, Puddey IB, Croft KD, Beilin LJ. Effect of eicosapentaenoic acid and docosahexaenoic acid on oxidative stress and inflammatory markers in treated-hypertensive type 2 diabetic subjects. Free Radic Biol Med. 2003;35:772-781.
20. Fujimoto WY. The growing prevalence of non-insulin-dependent diabetes in migrant asian populations and its implications for asia. Diabetes Res Clin Pract. 1992;15:167-183.
21. Roth GA, Fihn SD, Hokdad AH, Aekplakorn W, Hasegawa T, Lim SS. High total serum cholesterol, medication coverage and therapeutic control: An analysis of national health examination survey data from eight countries. Bulletin of the World Health Organization. 2011;89:92-101.
22. Kobayashi M, Sasaki S, Kawabata T, Hasegawa K, Akabane M, Tsugane S. Single measurement of serum phospholipid fatty acid as a biomarker of specific fatty acid intake in middle-aged japanese men. European Journal of Clinical Nutrition. 2001;55:643-650.